Jun Dou is a Doctoral Supervisor at Southeast University, China. In 1999, he was awarded the Excellent Doctoral Dissertation of Zhejiang University School of Medicine and In 2016, he won the first prize for teaching excellence at Southeast University. He has published 221 papers of various types, of which more than 60 are the first author, first author, and corresponding author or corresponding author of SCI papers. His research interests are Cancer Stem Cells and Tumor Immunity; Infection Immunity and Nucleic Acid Vaccines.

Helmut Popper after retirement has been rehired at the Medical University and act as a senior researcher devoted to thoracic pathology. He has published over 300 articles in peer-reviewed international journals. His focus is on lung pathology including tumor and non-tumor related diseases.

Currently, Assoc Prof Phawin Keskool has a position as the President of the Royal College of Otolaryngologists-Head and Neck Surgeons of Thailand (RCOT). He had been the Head of the Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University for 8 years (2015-2023). He has been working as a Head & Neck Laryngologist and Swallowing specialist for more than 20 years. He is the first person to set up ENT swallowing clinic in the faculty. He regularly publishes journals related to head and neck laryngology, swallowing, and also sleep otolaryngology.

Dr Aditya Punamiya is a Senior  Consultant in Surgical Oncology. In Surgical Oncology, he specializes in  GI-HPB (Gastrointestinal, Hepato-pancreatic-biliary, Retroperitoneal sarcomas, Cytoreductive Surgeries HIPEC, PIPAC, Minimally Invasive Surgeries and Robotic surgeries.), Gynecologic (ovarian, endometrial and Cervical Cancers)  and Urologic malignancies. He has 15 years of vast experience and has done several oral presentations and publications at National and International Conferences.

Gennady Machak is an oncologist at the Priorov Institute of Traumatology and Orthopedics, Moscow, Russia. He has 25 years of experience as an oncologist specializing in musculoskeletal tumors at the Blokhin Cancer Research Center and 12 years at the Priorov Institute. He has been a member of EMSOS since 2000. He regularly publishes in musculoskeletal oncology journals and regularly presents data at national and international scientific conferences. In recent years, his group has developed new approaches to non-surgical treatment of locally advanced and inoperable benign bone tumors.

Scott Skibo, MD currently serves as the Chief Medical Officer for Eon Health.  Prior to joining Eon Health in 2021, he has presented regularly at national scientific meetings focused on interventional pulmonology and lung cancer.  After finishing his pulmonary and critical care fellowship at Yale University in 2001, he gained over 20 years of experience in the thoracic oncology clinical space.  He co-developed the first system-wide incidental pulmonary nodule program in the United States in 2012.  He now leads the clinical team at Eon that oversees the quality and clinical outcomes for over 1000 US-based hospitals- helping to ensure the timely care for over 1 million patients per year.

Daniel A. Ayejoto is an accomplished environmental scientist with extensive experience in water quality analysis and pollution mitigation. He has developed pioneering models such as the Integrated Weighted Water Quality Index (IWQI) and Heavy Metal Toxicity Load (HMTL), which are used globally for assessing water pollutants. With a strong background in environmental science, Daniel has collaborated with international researchers and contributed to significant projects, including a specialized Water Quality Index for the Jiangsu National Wetland Park. His work, cited over 700 times, bridges practical laboratory skills and advanced computational research, addressing crucial environmental and public health concerns. Currently serving as an Environmental Chemist, Daniel ensures compliance with stringent environmental standards. As a leader in environmental research, his expertise enriches academic and professional platforms, notably through his work with organizations like the African Population & Health Research Center and influential publications that have set new benchmarks in environmental science.

Furkan TEKEDERELİ, is a nurse and researcher with expertise in oncology nursing. They hold a master’s degree in nursing and have extensive experience working with cancer patients in hospital settings, including those undergoing chemotherapy and radiotherapy. Their professional background includes providing direct care to oncology patients, focusing on symptom management and improving quality of life. Their research centers on developing strategies to enhance the quality of care for individuals undergoing cancer treatment, with a special emphasis on patient-centered approaches and holistic care practices.

Dr Despoina Pantazi has a permanent position as a teaching staff in the Laboratory of Biochemistry & Clinical Chemistry, at the Department of Chemistry, University of Ioannina, Greece. She is also the supervisor of the thesis of undergraduate students and master's thesis. She publishes in international journals on the mechanisms of cancer-associated thrombosis (CAT), and the effect of anticancer drugs, mainly TKIs. She received a two-month scientific leave abroad (June 2024) for research collaboration at the Institut Sant Pau of the Universitat Autónoma de Barcelona (UAB) in Spain. She is a member of the Steering Committee of the Institute for Study and Education in Thrombosis and Antithrombotic Education in Greece (ISETAT, www.imetha.gr/en) for the period 10/2022-10/2024 and 10/2024-10/2026.

EKBAL started anatomic pathology residency in 2014 at Mansoura University Hopsitals, Egypt. She applied for PhD degree in 2019 and now, she is a consultant histopathology at Mansoura University Hospitals, Egypt. She had an USAID grant in 2023 to the States, University of Kentucky, Kentucky. She has special interest in nephropathology.

Natalia Camejo is a medical oncologist and Associate Professor at the Oncology Service of the Hospital de Clínicas, Universidad de la República, Uruguay. She is a member of the National Research System (SNI) and has authored multiple publications focusing on real-world studies in oncology, treatment access, quality of care, adherence, and cancer survivorship. Her research emphasizes improving the effectiveness of oncological treatments and integrating patient-centered approaches into clinical practice.

Amr Ahmed El-Arabey is currently an Assistant Professor in the Pharmacology and Toxicology Department, Faculty of Pharmacy, AL-Azhar University, EGYPT, and King Khalid University, Saudi Arabia. Amr recieved his PhD from AL-Azhar University under the joint supervision of Egypt and the MD Anderson Cancer Centre at the University of Texas in Houston, Texas, USA. His Ph.D. thesis examines the regulatory activities of the well-known transcription factor GATA3 in macrophage-microenvironment interactions in cancer. Amr is the author of a book entitled '' Novel Use of Thymol and Carvacrol.© OmniScriptum GmbH & Co. KG. ISBN: 978-3-659-71247-0. Amr has published more than 60 scholarly publications in prestigious international journals. He serves on the editorial board of many speciality journals, including PLOS ONE and the World Journal of Experimental Medicine.

Berhe Dessalegn a senior cancer researcher at Adigrat University, Ethiopia, with over 17 years of experience in research and clinical practice. His work focuses on cancer epidemiology, risk factors, treatment, diagnostic delays, and the economic impact of cancer care in resource-limited settings.  He have published extensively in reputable international journals, shedding light on the challenges faced by patients and healthcare systems. Passionate about advancing cancer research, he remain committed to exploring innovative solutions to improve cancer care, particularly in low-resource countries like Ethiopia.

Ivan Vlahović works as a general surgeon at the Surgery Clinic of the Clinical Hospital Center Osijek, at the Department of Abdominal Surgery. His field of interest is colorectal and gastrointestinal surgery, especially colorectal and gastric cancer surgery. His scientific field of interest is colorectal cancer genetics and epigenetics. He earned his PhD in 2024., and the thesis he defended was named ‘The association between CDX2 expression loss and mismatch repair proteins expression in colorectal cancer patients’. He would like to present his results at this conference. 

Zhe Wu is the chief physician and master's supervisor, currently pursuing a doctoral degree at Chongqing Medical University. She is the director of the gynecology department at Yueyang Central Hospital in Hunan Province, China, and serves as a member of multiple academic committees. 

Jun Dou is a Doctoral Supervisor at Southeast University, China. In 1999, he was awarded the Excellent Doctoral Dissertation of Zhejiang University School of Medicine and In 2016, he won the first prize for teaching excellence at Southeast University. He has published 221 papers of various types, of which more than 60 are the first author, first author, and corresponding author or corresponding author of SCI papers. His research interests are Cancer Stem Cells and Tumor Immunity; Infection Immunity and Nucleic Acid Vaccines.

Scott Skibo, MD currently serves as the Chief Medical Officer for Eon Health.  Prior to joining Eon Health in 2021, he has presented regularly at national scientific meetings focused on interventional pulmonology and lung cancer.  After finishing his pulmonary and critical care fellowship at Yale University in 2001, he gained over 20 years of experience in the thoracic oncology clinical space.  He co-developed the first system-wide incidental pulmonary nodule program in the United States in 2012.  He now leads the clinical team at Eon that oversees the quality and clinical outcomes for over 1000 US-based hospitals- helping to ensure the timely care for over 1 million patients per year.